KUALA LUMPUR: Duopharma Biotech Bhd shareholders have approval the 1-for-3 bonus share issuance which the company had proposed on May 3, 2021.
The bonus shares would enable Duopharma shareholders to participate more in terms of share volume while retaining their stake, or percentage of shares.
This will also improve the liquidity of Duopharma Biotech shares.
"The confidence of our shareholders has always been very important for Duopharma Biotech, and this bonus issue is another way we are rewarding them for their trust in us.
"We will continue to pursue new business opportunities that are suitable and promising, and strive towards stronger performance moving forward," said chairman Tan Seri Datin Paduka Siti Sa'diah Sh Bakir in a statement today.
Duopharma Biotech said the approval for the issuances of 235 million bonus shares was received during a shareholders meeting today.
"The exercise will entail the issuance of 235 million bonus shares in Duopharma Biotech on the basis of one bonus share for every three existing Duopharma Biotech shares held.
The entitlement date will be announced at a later date, the company said.
Ends